Correlation Between Mineralys Therapeutics, and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Passage Bio, you can compare the effects of market volatilities on Mineralys Therapeutics, and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Passage Bio.
Diversification Opportunities for Mineralys Therapeutics, and Passage Bio
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mineralys and Passage is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Passage Bio go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Passage Bio
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Passage Bio. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 2.51 times less risky than Passage Bio. The stock trades about -0.01 of its potential returns per unit of risk. The Passage Bio is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Passage Bio on November 2, 2024 and sell it today you would lose (8.00) from holding Passage Bio or give up 12.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Passage Bio
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Passage Bio |
Mineralys Therapeutics, and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Passage Bio
The main advantage of trading using opposite Mineralys Therapeutics, and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Mineralys Therapeutics, vs. Dine Brands Global | Mineralys Therapeutics, vs. El Pollo Loco | Mineralys Therapeutics, vs. Flanigans Enterprises | Mineralys Therapeutics, vs. Saia Inc |
| Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |